1. Durability of pain relief.
Durability of pain relief. (A) Proportion of subjects in the peripheral nerve stimulation therapy group reporting ≥50% reduction of average pain at each month. *P<0.05 versus placebo group at the end of the placebo period. (Statistical analysis pending completion of prospective follow-up for months 7–12.) (B) Average residual limb pain (RLP) and phantom limb pain (PLP) scores among responders (those reporting ≥50% reductions in pain at each month of follow-up).
Christopher Gilmore et al. Reg Anesth Pain Med 2019;44:
© American Society of Regional Anesthesia & Pain Medicine Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.